Belantamab mafodotin (Blenrep)

Belantamab mafodotin (Blenrep) is a targeted prescription medication used to treat multiple myeloma. It works as an antibody-drug conjugate, which means it pairs an antibody that finds specific proteins on myeloma cells with a cancer drug that destroys those cells from the inside. This topic provides practical information about how the medication is given, what to expect during treatment, and how to manage potential side effects, such as changes in vision. You can also connect with other patients and caregivers to share experiences and learn how this therapy fits into everyday life.